More new CPT codes approved for COVID-19 vaccines

Following its publication of codes for the Pfizer and Moderna COVID-19 vaccines, the American Medical Association’s (AMA’s) CPT Editorial Panel has approved a new unique code for the vaccine developed by AstraZeneca and the University of Oxford. The panel has also approved unique codes for the administration of both doses of that vaccine.

The new CPT code and descriptor for the AstraZeneca/Oxford vaccine is:

• 91302: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10¹⁰ viral particles/0.5mL dosage, for intramuscular use

The corresponding administration codes are:

• 0021A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10¹⁰ viral particles/0.5mL dosage; first dose
• 0022A Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10¹⁰ viral particles/0.5mL dosage; second dose

These new codes take effect upon the vaccine receiving emergency use authorization or approval from the Food and Drug Administration. More information is available on the AMA website.

— Kent Moore, senior strategist for physician payment, American Academy of Family Physicians